Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CALD1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | AKIRIN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | ARHGEF17 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | C4orf46 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CCDC25 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PPP1R8 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SRSF10 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | GREB1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | L3MBTL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |